IL161468A0 - Method of producing human beta cell lines - Google Patents

Method of producing human beta cell lines

Info

Publication number
IL161468A0
IL161468A0 IL16146802A IL16146802A IL161468A0 IL 161468 A0 IL161468 A0 IL 161468A0 IL 16146802 A IL16146802 A IL 16146802A IL 16146802 A IL16146802 A IL 16146802A IL 161468 A0 IL161468 A0 IL 161468A0
Authority
IL
Israel
Prior art keywords
human beta
pancreatic
beta cell
cell lines
producing human
Prior art date
Application number
IL16146802A
Other languages
English (en)
Original Assignee
Univ Paris 7 Denis Diderot Ct
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Univ Paris 7 Denis Diderot Ct filed Critical Univ Paris 7 Denis Diderot Ct
Publication of IL161468A0 publication Critical patent/IL161468A0/xx

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N5/00—Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor
    • C12N5/06—Animal cells or tissues; Human cells or tissues
    • C12N5/0602—Vertebrate cells
    • C12N5/0603—Embryonic cells ; Embryoid bodies
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N5/00—Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor
    • C12N5/06—Animal cells or tissues; Human cells or tissues
    • C12N5/0602—Vertebrate cells
    • C12N5/0676—Pancreatic cells
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/12—Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells
    • A61K35/37—Digestive system
    • A61K35/39—Pancreas; Islets of Langerhans
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
    • A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P5/00—Drugs for disorders of the endocrine system
    • A61P5/48—Drugs for disorders of the endocrine system of the pancreatic hormones
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P5/00—Drugs for disorders of the endocrine system
    • A61P5/48—Drugs for disorders of the endocrine system of the pancreatic hormones
    • A61P5/50—Drugs for disorders of the endocrine system of the pancreatic hormones for increasing or potentiating the activity of insulin
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N5/00—Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor
    • C12N5/06—Animal cells or tissues; Human cells or tissues
    • C12N5/0602—Vertebrate cells
    • C12N5/0676—Pancreatic cells
    • C12N5/0678—Stem cells; Progenitor cells; Precursor cells
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2510/00—Genetically modified cells
    • C12N2510/04—Immortalised cells

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Biomedical Technology (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Zoology (AREA)
  • Biotechnology (AREA)
  • General Health & Medical Sciences (AREA)
  • Wood Science & Technology (AREA)
  • Genetics & Genomics (AREA)
  • Cell Biology (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Medicinal Chemistry (AREA)
  • Diabetes (AREA)
  • Microbiology (AREA)
  • General Engineering & Computer Science (AREA)
  • Biochemistry (AREA)
  • Developmental Biology & Embryology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Epidemiology (AREA)
  • Endocrinology (AREA)
  • Virology (AREA)
  • Immunology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Nutrition Science (AREA)
  • Physiology (AREA)
  • Obesity (AREA)
  • Hematology (AREA)
  • Emergency Medicine (AREA)
  • Reproductive Health (AREA)
  • Gynecology & Obstetrics (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
IL16146802A 2001-10-19 2002-10-18 Method of producing human beta cell lines IL161468A0 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US09/981,750 US20030077256A1 (en) 2001-10-19 2001-10-19 Pancreas regeneration using embryonic pancreatic cells
PCT/IB2002/004599 WO2003033685A2 (en) 2001-10-19 2002-10-18 Method of producing human beta cell lines

Publications (1)

Publication Number Publication Date
IL161468A0 true IL161468A0 (en) 2004-09-27

Family

ID=25528625

Family Applications (1)

Application Number Title Priority Date Filing Date
IL16146802A IL161468A0 (en) 2001-10-19 2002-10-18 Method of producing human beta cell lines

Country Status (18)

Country Link
US (2) US20030077256A1 (de)
EP (1) EP1456356B1 (de)
JP (1) JP2005505635A (de)
KR (1) KR20040080430A (de)
CN (1) CN1662644A (de)
AT (1) ATE452967T1 (de)
BR (1) BR0213429A (de)
CA (1) CA2463979A1 (de)
DE (1) DE60234862D1 (de)
GB (1) GB2397825B (de)
HR (1) HRP20040446A2 (de)
HU (1) HUP0600102A2 (de)
IL (1) IL161468A0 (de)
NZ (1) NZ532965A (de)
PL (1) PL370167A1 (de)
RU (1) RU2004115108A (de)
WO (1) WO2003033685A2 (de)
ZA (1) ZA200403646B (de)

Families Citing this family (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA2622422A1 (en) * 2005-09-15 2007-03-29 Mark Mercola Methods for screening for compounds that modulate insulin promoter activity
JP5636192B2 (ja) * 2007-02-21 2014-12-03 エス・ア・エール・エル アンドセルＳａｒｌ Ｅｎｄｏｃｅｌｌｓ 糖尿病の診断のためのヒト膵臓β細胞株
US8859286B2 (en) * 2013-03-14 2014-10-14 Viacyte, Inc. In vitro differentiation of pluripotent stem cells to pancreatic endoderm cells (PEC) and endocrine cells
AU2014278178B2 (en) 2013-06-11 2021-01-21 President And Fellows Of Harvard College SC-beta cells and compositions and methods for generating the same
CN107614678B (zh) 2014-12-18 2021-04-30 哈佛学院校长同事会 干细胞来源的β细胞的产生方法及其使用方法
US10443042B2 (en) 2014-12-18 2019-10-15 President And Fellows Of Harvard College Serum-free in vitro directed differentiation protocol for generating stem cell-derived beta cells and uses thereof
ES2985135T3 (es) 2014-12-18 2024-11-04 Harvard College Procedimientos para generar células ß derivadas de células madre y usos de las mismas
WO2019099725A1 (en) 2017-11-15 2019-05-23 Semma Therapeutics, Inc. Islet cell manufacturing compositions and methods of use
WO2019169351A1 (en) 2018-03-02 2019-09-06 Semma Therapeutics, Inc. Methods of enhancing stem cell differentiation into beta cells
EP3833365A4 (de) 2018-08-10 2022-05-11 Vertex Pharmaceuticals Incorporated Aus stammzellen gewonnene inseldifferenzierung
CN110029130A (zh) * 2019-04-24 2019-07-19 皖南医学院第一附属医院（皖南医学院弋矶山医院） 基于CRISPR/Cas9系统在Beta-TC-6细胞株中剔除Sidt2基因方法
WO2025168061A1 (en) * 2024-02-09 2025-08-14 Endocell Therapeutics Inc Methods for preparing endoderm stem cells and islets derived therefrom

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5723333A (en) * 1995-02-10 1998-03-03 Regents Of The University Of California Human pancreatic cell lines: developments and uses

Also Published As

Publication number Publication date
GB2397825A (en) 2004-08-04
HUP0600102A2 (en) 2006-05-29
KR20040080430A (ko) 2004-09-18
EP1456356A2 (de) 2004-09-15
US20030219418A1 (en) 2003-11-27
HRP20040446A2 (en) 2005-04-30
BR0213429A (pt) 2004-11-09
PL370167A1 (en) 2005-05-16
GB0411052D0 (en) 2004-06-23
EP1456356B1 (de) 2009-12-23
WO2003033685A2 (en) 2003-04-24
ATE452967T1 (de) 2010-01-15
CA2463979A1 (en) 2003-04-24
DE60234862D1 (de) 2010-02-04
CN1662644A (zh) 2005-08-31
RU2004115108A (ru) 2005-02-10
ZA200403646B (en) 2005-01-26
GB2397825B (en) 2006-02-22
WO2003033685A3 (en) 2004-05-27
US20030077256A1 (en) 2003-04-24
NZ532965A (en) 2006-04-28
JP2005505635A (ja) 2005-02-24

Similar Documents

Publication Publication Date Title
GB2397825B (en) Method of producing human beta cell lines
AU2003208567A8 (en) Methods of inducing differentiation in stem cells, methods of generating tissue using scaffold matrices derived from micro-organs and stem cells, methods of producing adult stem cells and methods of continuously generating stem cells by implantation of micro-organs as sources of stem cells
DE69525151D1 (de) Methoden zur krankheitsbehandlung unter verwendung von sertoli-zellen und allotransplantat oder xenotransplantat
NZ597965A (en) Methods of preparing and using stem cell compositions and kits comprising the same
BR0108977A (pt) Compostos azacìclicos para uso no tratamento de doenças relaciondas com serotonina
TR200001250T2 (tr) Ati-CD40L bileşikleri ile lupus nefritis tedavisi
WO2001068828A3 (en) Compositions and methods for regulated protein expression in gut
AU6090799A (en) Transgenic c. elegans as a model organism for research into alzheimer's disease
EP1425297A4 (de) Isolierung von nervenstammzellen unter verwendung von gangliosiden und anderen oberflächenmarkern
DE60039160D1 (de) Verwendung von erbb-rezeptorliganden zur behandlung von diabetes
ATE484576T1 (de) Chimäre bauchspeicheldrüse
IL137410A0 (en) A method for the production of transgenic plants using apical shoot tips
WO2004030628A3 (en) Adult bone marrow derived stem cells
BR0009636B1 (pt) processo para a preparação de insulina madura ou um derivado de insulina madura.
RU96122257A (ru) Способ лечения расстройств центральной нервной системы
MXPA02002444A (es) Metodo para generar celulas y tejidos inmunocompatibles, utilizando tecnicas de transferencia nuclear.
GB9907048D0 (en) Novel glucocorticoid receptor ligands for the treatment of meta bolic disorders
PL1664307T3 (pl) Nowy, specyficzny dla bielma promotor roślinny dla roślin uprawnych
BR9911211A (pt) Método para indução de apoptose em células
WO2004078956A3 (en) Process for detaching confluent cells from two dimensional microsupports and its application for preparing transplants
DE59914749D1 (de) Ustilipide, verfahren zu deren herstellung sowie deren verwendung
MX9709748A (es) Uso de lineas celulares fetales neuro-derivadas para terapia de trasplante.
UA39614A (uk) Спосіб корекції функціонального стану міокарда у лабораторних тварин пізнього онтогенезу
ATE525463T1 (de) Genomisches tabaknikotindemethylaseklon und verwendung
UA42521A (uk) Спосіб лікування епілепсії